Electronic Journal of General Medicine

Declaration of Conflict of Interest: No conflict of interest is declared by author(s).

• Harpel PC, Zhang X, Borth W. Homocysteine and hemostasis: pathogenetic mechanisms predisposing to thrombosis. The Journal of nutrition. 1996;126(4S):1285S. https://doi.org/10.1093/jn/126.suppl_4.1285S PMid:8642472.
• van Beynum IM, Kapusta L, den Heijer M, Vermeulen SH, Kouwenberg M, Daniëls O, et al. Maternal MTHFR 677C> T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. European heart journal. 2006;27(8):981-7. https://doi.org/10.1093/eurheartj/ehi815 PMid:16524890.
• Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE. Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: the Hordaland Homocysteine Study. The American journal of medicine. 2004;117(1):26-31. https://doi.org/10.1016/j.amjmed.2004.01.019 PMid:15210385.
• Caccamo D, Condello S, Gorgone G, Crisafulli G, Belcastro V, Gennaro S, et al. Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia. Neuromolecular medicine. 2004;6(2-3):117-26. https://doi.org/10.1385/NMM:6:2-3:117.
• Pan X, Wang P, Yin X, Liu X, Li D, Li X, et al. Association between maternal MTHFR polymorphisms and nonsyndromic cleft lip with or without cleft palate in offspring, a meta-analysis based on 15 case-control studies. International journal of fertility & sterility. 2015;8(4):463. https://doi.org/10.22074/ijfs.2015.4186 PMid:25780529 PMCid:PMC4355933.
• Dean J, Robertson Z, Reid V, Wang Q, Hailey H, Moore S, et al. A high frequency of the MTHFR 677C> T polymorphism in Scottish women with epilepsy: possible role in pathogenesis. Seizure. 2008;17(3):269-75. https://doi.org/10.1016/j.seizure.2007.08.003 PMid:17904392.
• Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studies. Journal of Thrombosis and Haemostasis. 2005;3(2):292-9. https://doi.org/10.1111/j.1538-7836.2005.01141.x PMid:15670035.
• Hoffer LJ. Homocysteine remethylation and trans-sulfuration. Metabolism. 2004;53(11):1480-3. https://doi.org/10.1016/j.metabol.2004.06.003 PMid:15536605.
• Stover PJ. One-carbon metabolism–genome interactions in folate-associated pathologies. The Journal of nutrition. 2009;139(12):2402-5. https://doi.org/10.3945/jn.109.113670 PMid:19812215 PMCid:PMC2777484.
• Turgal M, Yazicioglu A, Ozyuncu O, Beksac M. Impaired DNA methylation leading to heterotrisomy. Journal of Obstetrics and Gynaecology. 2013;33(8):904. https://doi.org/10.3109/01443615.2013.838547 PMid:24219741.
• Castro R, Rivera I, Ravasco P, Camilo M, Jakobs C, Blom H, et al. 5, 10-methylenetetrahydrofolate reductase (MTHFR) 677C→ T and 1298A→ C mutations are associated with DNA hypomethylation. Journal of medical genetics. 2004;41(6):454-8. https://doi.org/10.1136/jmg.2003.017244 PMid:15173232 PMCid:PMC1735802.
• Şahin TG, Şahin N, Besler T, Beksaç S. Methionine Restricted Diet; Clinical Application. Gynecology Obstetrics & Reproductive Medicine. 2012;18(1):54-61.
• Solanky N, Jimenez AR, D'Souza S, Sibley C, Glazier J. Expression of folate transporters in human placenta and implications for homocysteine metabolism. Placenta. 2010;31(2):134-43. https://doi.org/10.1016/j.placenta.2009.11.017 PMid:20036773.
• Kosar A, Kasapoglu B, Kalyoncu S, Turan H, Balcik OS, Gümüs EI. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study. Blood Coagulation & Fibrinolysis. 2011;22(1):14-8. https://doi.org/10.1097/MBC.0b013e32834013f2 PMid:21042205.
• Lykke J, Bare L, Olsen J, Lagier R, Arellano A, Tong C, et al. Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort. Journal of Thrombosis and Haemostasis. 2012;10(7):1320-5. https://doi.org/10.1111/j.1538-7836.2012.04773.x PMid:22578003.
• McEwen BJ. Methylenetetrahydrofolate Reductase (MTHFR): mythology or polymorphism (ology)? Advances in Integrative Medicine. 2016;3(3):79-81. https://doi.org/10.1016/j.aimed.2017.02.005.
• Perez ABA, D'Almeida V, Vergani N, de Oliveira AC, de Lima FT, Brunoni D. Methylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. American Journal of Medical Genetics Part A. 2003;119(1):20-5. https://doi.org/10.1002/ajmg.a.10059 PMid:12707953.
• Sazci A, Ergul E, Kaya G, Kara I. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell biochemistry and function. 2005;23(1):51-4. https://doi.org/10.1002/cbf.1132 PMid:15386535.
• Ozarda Y, Sucu DK, Hizli B, Aslan D. Rate of T alleles and TT genotype at MTHFR 677C‐> T locus or C alleles and CC genotype at MTHFR 1298A‐> C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals. Cell biochemistry and function. 2009;27(8):568-77. https://doi.org/10.1002/cbf.1610 PMid:19764044.
• Uçar F, Sönmez M, Ovalı E, Özmenoǧlu M, Kartı SS, Yılmaz M, et al. MTHFR C677T polymorphism and its relation to ischemic stroke in the Black Sea Turkish population. American journal of hematology. 2004;76(1):40-3. https://doi.org/10.1002/ajh.20050 PMid:15114595.
• Izmirli M, Inandiklioglu N, Abat D, Alptekin D, Demirhan O, Tansug Z, et al. MTHFR gene polymorphisms in bladder cancer in the Turkish population. Asian Pac J Cancer Prev. 2011;12(7):1833-5. PMid:22126575.
• Çetintaş VB, Gündüz C. Association between polymorphism of MTHFR c. 677C> T and risk of cardiovascular disease in Turkish population: a meta-analysis for 2.780 cases and 3.022 controls. Molecular biology reports. 2014;41(1):397-409. https://doi.org/10.1007/s11033-013-2873-z PMid:24264431.
• Caner M, Bircan R, Sevinç D, Benli F, Güney AI, Kurtoglu N. MTHFR, prothrombin and Factor V gene variants in Turkish patients with coronary artery stenosis. Genetics and Molecular Biology. 2008;31(4):836-8. https://doi.org/10.1590/S1415-47572008005000023.
• Yasa MH, Bolaman Z, Yukselen V, Kadikoylu G, Karaoglul A, Batun S. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients. Hepato-gastroenterology. 2006;54(77):1438-42. PMID:17708272.
• Sener EF, Oztop DB, Ozkul Y. MTHFR gene C677T polymorphism in autism spectrum disorders. Genetics research international. 2014;2014. http://dx.doi.org/10.1155/2014/698574.
• Deligezer U, Akisik EE, Dalay N. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population. in vivo. 2005;19(5):889-93.
• Djordjevic V, Rakicevic L, Mikovic D, Kovac M, Miljic P, Radojkovic D, et al. Prevalence of factor V leiden, factor V cambridge, factor II G20210A and methylenetetrahydrofolate reductase C677T mutations in healthy and thrombophilic Serbian populations. Acta haematologica. 2004;112(4):227-9. https://doi.org/10.1159/000081280 PMid:15564739.
• Angelopoulou K, Nicolaides A, Constantinou Deltas C. Prevalence of genetic mutations that predispose to thrombophilia in a Greek Cypriot population. Clin Appl Thromb Hemost. 2000;6(2):104-7. https://doi.org/10.1177/107602960000600211 PMid:10775032.
• Sazci A, Ergul E, Kaya G, Kara I. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem Funct. 2005;23(1):51-4. https://doi.org/10.1002/cbf.1132 PMid:15386535.
• Mao R, Fan Y, Chen F, Sun D, Bai J, Fu S. Methylenetetrahydrofolate reductase gene polymorphisms in 13 Chinese ethnic populations. Cell Biochem Funct. 2008;26(3):352-8. https://doi.org/10.1002/cbf.1450 PMid:18098118.
• Almawi WY, Finan RR, Tamim H, Daccache JL, Irani-Hakime N. Differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene among the Lebanese population. Am J Hematol. 2004;76(1):85-7. https://doi.org/10.1002/ajh.20047 PMid:15114606.
• Ekim M, Ekim H, Yilmaz YK. The prevalence of Factor V Leiden, prothrombin G20210A, MTHFR C677T and MTHFR A1298C mutations in healthy Turkish population. Hippokratia. 2015;19(4):309-13. PMid:27688694 PMCid:PMC5033140.

Vancouver

Gumruk F, Orgul G, Akgun Dogan O, Tanacan A, Karaagaoglu E, Beksac MS. The prevalence of homozygous MTHFR polymorphism(s) in a Turkish university hospital population that necessitated MTHFR polymorphism investigation. ELECTRON J GEN MED. 2018;15(4):em57. https://doi.org/10.29333/ejgm/89674

APA

Gumruk, F., Orgul, G., Akgun Dogan, O., Tanacan, A., Karaagaoglu, E., & Beksac, M. S. (2018). The prevalence of homozygous MTHFR polymorphism(s) in a Turkish university hospital population that necessitated MTHFR polymorphism investigation. Electronic Journal of General Medicine, 15(4), em57. https://doi.org/10.29333/ejgm/89674

AMA

Gumruk F, Orgul G, Akgun Dogan O, Tanacan A, Karaagaoglu E, Beksac MS. The prevalence of homozygous MTHFR polymorphism(s) in a Turkish university hospital population that necessitated MTHFR polymorphism investigation. ELECTRON J GEN MED. 2018;15(4), em57. https://doi.org/10.29333/ejgm/89674

Chicago

Gumruk, Fatma, Gokcen Orgul, Ozlem Akgun Dogan, Atakan Tanacan, Ergun Karaagaoglu, and Mehmet Sinan Beksac. "The prevalence of homozygous MTHFR polymorphism(s) in a Turkish university hospital population that necessitated MTHFR polymorphism investigation". Electronic Journal of General Medicine 2018 15 no. 4 (2018): em57. https://doi.org/10.29333/ejgm/89674

Harvard

Gumruk, F., Orgul, G., Akgun Dogan, O., Tanacan, A., Karaagaoglu, E., and Beksac, M. S. (2018). The prevalence of homozygous MTHFR polymorphism(s) in a Turkish university hospital population that necessitated MTHFR polymorphism investigation. Electronic Journal of General Medicine, 15(4), em57. https://doi.org/10.29333/ejgm/89674

MLA

Gumruk, Fatma et al. "The prevalence of homozygous MTHFR polymorphism(s) in a Turkish university hospital population that necessitated MTHFR polymorphism investigation". Electronic Journal of General Medicine, vol. 15, no. 4, 2018, em57. https://doi.org/10.29333/ejgm/89674